Results 201 to 210 of about 414,897 (392)
A method for serum octanoate in hepatic cirrhosis and hepatic encephalopathy. [PDF]
, 1977 Joseph L. Rabinowitz +7 more
openalex +1 more source
Cytometry Part B: Clinical Cytometry, EarlyView.ABSTRACT Anticipating the evolution of septic patients with community‐acquired pneumonia (CAP) is challenging for front‐line physicians in the Emergency Department (ED). Prognosis depends mainly on early identification, antibiotics, organ support, but also immune status.
Thomas Lafon +4 more
wiley +1 more source
Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury
Journal of Neuropathology and Experimental Neurology, 2009 A. Mckee +9 more
semanticscholar +1 more source
Commentary: Three questions for the study of traumatic brain injury in animals
The Anatomical Record, EarlyView.
Gregory Hollin
wiley +1 more source
Infant Death due to Cannabis Ingestion
Drug Testing and Analysis, EarlyView.ABSTRACT A child died in the emergency room of a local hospital a few hours after ingesting a substance the color of cork and the consistency of earth. At home, a modest amount of resinous substance was found. At the hospital, the child exhibited alterations in walking, balance, and consciousness.
Donata Favretto +9 more
wiley +1 more source
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Hepatology, EarlyView., 2022 Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran +17 more
wiley +1 more source